Skip to main content
logo
Delta-Fly Pharma, Inc. (TYO:4598)
Japan flag Japan · Delayed Price · Currency is JPY
108.00
-2.00 (-1.82%)
Aug 6, 2026, 3:30 PM JST

Delta-Fly Pharma Balance Sheet

Millions JPY. Fiscal year is Apr - Mar.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
1453381,4178441,268
Cash & Short-Term Investments
1453381,4178441,268
Cash Growth
-57.10%-76.15%67.89%-33.44%-39.27%
Other Receivables
5751---
Receivables
5751---
Prepaid Expenses
32235
Other Current Assets
2313197
Total Current Assets
2073941,4328661,280
Property, Plant & Equipment
3536383839
Long-Term Investments
32213
Other Long-Term Assets
12212
Total Assets
2464341,4749061,324

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Current Income Taxes Payable
21015423811389
Other Current Liabilities
22322
Total Current Liabilities
21215624111591
Other Long-Term Liabilities
12211
Total Liabilities
21315824311692

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
5,8045,1134,7313,7953,352
Additional Paid-In Capital
5,7845,0934,7113,7753,332
Retained Earnings
-11,557-9,931-8,210-6,780-5,451
Comprehensive Income & Other
21-1--1
Shareholders' Equity
332761,2317901,232
Total Liabilities & Equity
2464341,4749061,324

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash (Debt)
1453381,4178441,268
Net Cash Growth
-57.10%-76.15%67.89%-33.44%-39.27%
Net Cash Per Share
12.5338.41197.05148.95234.09
Filing Date Shares Outstanding
12.499.718.226.295.42
Total Common Shares Outstanding
12.499.718.226.295.42
Working Capital
-52381,1917511,189
Book Value Per Share
2.6428.42149.72125.68227.33
Tangible Book Value
332761,2317901,232
Tangible Book Value Per Share
2.6428.42149.72125.68227.33